Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab
Authors:
- Omer KaradagOKOmer Karadag
- Ali AkdoganAAAli Akdogan
- Bunyamin KisacikBKBunyamin Kisacik
- Mustafa ErmanMEMustafa Erman
- Sibel ErguvenSESibel Erguven
- A. Ihsan ErtenliAEA. Ihsan Ertenli
- 1 January 2007
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 39 (5) , 475-478
Abstract
Patients with rheumatoid arthritis (RA) have an increased risk of infection as a result of alterations in immune regulation, debility, and comorbid illnesses. TNF-alpha is of central importance in the pathophysiological responses to infection and inflammation, and plays a crucial role in host defence. Pneumocystis carinii is an opportunistic pathogen that commonly affects individuals with inadequate T-cell mediated immune response. Patients with acquired immune deficiency, as well as those receiving immunosuppressive drugs for various conditions have an increased risk of P. carinii pneumonia (PCP). We report the development of PCP in a woman with RA shortly after the initiation of anti-TNF-alpha treatment with adalimumab.Keywords
This publication has 7 references indexed in Scilit:
- Infectious complications of tumor necrosis factor‐α antagonistsInternational Journal of Dermatology, 2005
- Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseasesAutoimmunity Reviews, 2005
- Pneumocystis carinii Pneumonia During Maintenance Anti–Tumor Necrosis Factor-α Therapy with Infliximab for Crohn’s DiseaseInflammatory Bowel Diseases, 2004
- Infections and biological therapy in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2003
- Pneumocystis carinii pneumonia following a second infusion of infliximabRheumatology, 2002
- Low-Dose Methotrexate as a Risk Factor for Pneumocystis carinii PneumoniaMilitary Medicine, 1996
- Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infectionInfection and Immunity, 1992